UE
Uy Ear Mizuho Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Acadia Pharmaceuticals
ACAD
$4.26B
| $25.26 | $24 |
5%
downside
| Neutral | 29 days ago |
|
|
MBX
2
MBX Biosciences, Inc. Common Stock
MBX
$388M
| $11.55 | $38 |
229%
upside
| Outperform | 1 month ago |
|
3
Sarepta Therapeutics
SRPT
$1.96B
| $18.71 | $14 |
25%
downside
| Neutral | 1 month ago |
|
|
TECX
4
Tectonic Therapeutic, Inc. Common Stock
TECX
$314M
| $16.80 | $85 |
406%
upside
| Outperform | 3 months ago |
|
5
Arcutis Biotherapeutics
ARQT
$2.06B
| $17.15 | $21 |
22%
upside
| Outperform | 6 months ago |
|
6
uniQure
QURE
$985M
| $17.95 | $20 |
11%
upside
| Neutral | 8 months ago |
|
7
Alkermes
ALKS
$4.94B
| $29.94 | $40 |
34%
upside
| Outperform | 9 months ago |
|
8
Cartesian Therapeutics
RNAC
$277M
| $10.64 | $40 |
276%
upside
| Buy | 1 year ago |
|
9
Evolus
EOLS
$495M
| $7.66 | $23 |
200%
upside
| Buy | 1 year ago |
|
10
Neurocrine Biosciences
NBIX
$14.3B
| $144.10 | $140 |
3%
downside
| Neutral | 1 year ago |
|
11
Johnson & Johnson
JNJ
$430B
| $178.43 | $40 |
78%
downside
| Buy | 2 years ago |
|
12
Ocugen
OCGN
$322M
| $1.03 | $3 |
191%
upside
| Buy | 2 years ago |
|